NL7907317A - Contraceptiemiddel voor mannen. - Google Patents

Contraceptiemiddel voor mannen. Download PDF

Info

Publication number
NL7907317A
NL7907317A NL7907317A NL7907317A NL7907317A NL 7907317 A NL7907317 A NL 7907317A NL 7907317 A NL7907317 A NL 7907317A NL 7907317 A NL7907317 A NL 7907317A NL 7907317 A NL7907317 A NL 7907317A
Authority
NL
Netherlands
Prior art keywords
compound
compound according
methoxy
methyl
formula
Prior art date
Application number
NL7907317A
Other languages
English (en)
Dutch (nl)
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NL7907317A publication Critical patent/NL7907317A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0073—Sulfur-containing hetero ring
    • C07J71/0078—Sulfur-containing hetero ring containing only sulfur
    • C07J71/0084—Episulfides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0029—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/005—3 membered carbocyclic rings in position 12
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C07J71/0047—Nitrogen only at position 2(3)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0057—Nitrogen and oxygen
    • C07J71/0063—Nitrogen and oxygen at position 2(3)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0073—Sulfur-containing hetero ring
    • C07J71/0094—Sulfur-containing hetero ring containing sulfur and nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7907317A 1978-10-10 1979-10-02 Contraceptiemiddel voor mannen. NL7907317A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/949,797 US4297350A (en) 1978-10-10 1978-10-10 Male contraceptive steroids and methods of use
US94979778 1978-10-10

Publications (1)

Publication Number Publication Date
NL7907317A true NL7907317A (nl) 1980-04-14

Family

ID=25489549

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7907317A NL7907317A (nl) 1978-10-10 1979-10-02 Contraceptiemiddel voor mannen.

Country Status (8)

Country Link
US (1) US4297350A (it)
JP (1) JPS5555200A (it)
CH (1) CH643565A5 (it)
DE (1) DE2940132A1 (it)
FR (1) FR2438663A1 (it)
GB (1) GB2032924B (it)
IT (1) IT1124568B (it)
NL (1) NL7907317A (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684636A (en) * 1985-06-24 1987-08-04 Sterling Drug Inc. Antiandrogenic sulfonylsteroidopyrazoles and processes for preparation method of use and compositions thereof
US5134135A (en) * 1990-06-21 1992-07-28 Sterling Drug Inc. Antiandrogenic sulfonylsteroidooxazoles
DE4021433A1 (de) * 1990-07-04 1992-01-09 Schering Ag Antiandrogene mit steroid(3,2-c)pyrazol-struktur
AU2769092A (en) * 1991-10-23 1993-05-21 Akzo Nobel N.V. Pest control compositions
IL105050A0 (en) * 1992-03-27 1993-07-08 Lilly Co Eli Steroid derivatives
JP2510927B2 (ja) * 1992-06-04 1996-06-26 秩父小野田株式会社 有害物処理容器
JPH06218028A (ja) * 1992-10-02 1994-08-09 Eisai Co Ltd 湿製錠の成型方法とその装置及び湿製錠
DE69634039T2 (de) * 1995-06-06 2005-12-08 Euro-Celtique S.A. Steroidderivate der Androstan- und der Pregnanreihe
US6780853B1 (en) 1995-06-06 2004-08-24 Euro-Celtique S.A. Neuroactive steroids of the androstane and pregnane series
US5763432A (en) * 1997-01-29 1998-06-09 Sri International Steriod inhibitors of estrone sulfatase and associated pharmaceutical compositions and methods of use
CA2372342A1 (en) * 1999-04-29 2000-11-09 Derk J. Hogenkamp 3.alpha.-hydroxy-3.beta. methoxymethyl-21-heterocycle substituted steroids with anesthetic activity
WO2020123855A1 (en) 2018-12-12 2020-06-18 University Of Washington Inhibitor compounds for male contraception
EP3962921A4 (en) * 2019-04-27 2023-01-25 Health Research, Inc. COUMARIN-MODIFIED ANDROGENS FOR THE TREATMENT OF PROSTATE CANCER

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3052693A (en) * 1959-03-13 1962-09-04 Schering Ag Steroid alkyl ethers and process therefor
US3290293A (en) * 1961-12-01 1966-12-06 Merck & Co Inc 4-androsteno-[3, 2-c] pyrazoles
US3301850A (en) * 1964-12-01 1967-01-31 Searle & Co 17-oxygenated-5alpha-androstane-2alpha, 3alpha-episulfides
US3380886A (en) * 1965-04-07 1968-04-30 Upjohn Co 7alpha-methyl-3beta-hydroxy-5-androstenes
GB1185844A (en) * 1967-08-08 1970-03-25 Merck & Co Inc 2',3'alpha-Tetrahydrofuran-2'-Spiro-17-Androstene Compounds
GB1327910A (en) * 1971-04-20 1973-08-22 Snytex Corp 2alpha-methyl-17beta-cyclopentyloxy-5alpha-androstan- 3-one
US4053489A (en) * 1971-04-21 1977-10-11 Pierre Charles Wirth Oestratriene diethers
FR2210394B1 (it) * 1972-12-19 1976-07-02 Roussel Uclaf
DE2439082A1 (de) * 1974-08-12 1976-02-26 Schering Ag 17 alpha-hydroxy-1,3,5(10),15-oestratetraene und verfahren zu ihrer herstellung
FR2285138A1 (fr) * 1974-09-20 1976-04-16 Roussel Uclaf Nouveau derive steroide trienique, son procede de preparation et son application comme medicament
US3980638A (en) * 1974-09-20 1976-09-14 The Upjohn Company Testosterone derivatives
CH606101A5 (it) * 1975-01-30 1978-10-13 Ciba Geigy Ag

Also Published As

Publication number Publication date
DE2940132A1 (de) 1980-04-24
FR2438663A1 (fr) 1980-05-09
US4297350A (en) 1981-10-27
FR2438663B1 (it) 1983-06-03
GB2032924A (en) 1980-05-14
GB2032924B (en) 1982-12-22
CH643565A5 (de) 1984-06-15
IT7926267A0 (it) 1979-10-04
IT1124568B (it) 1986-05-07
JPS5555200A (en) 1980-04-22

Similar Documents

Publication Publication Date Title
EP1272505B1 (de) 8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate
NL7907317A (nl) Contraceptiemiddel voor mannen.
US4160027A (en) Steroid cyanoketones and intermediates
JP2000503980A (ja) 新規１９―ノル−プレグネン誘導体類
DK168294B1 (da) 6-alkyl-11-aminophenyløstran- og 6-alkyl-11-aminophenyl-19-norpregnanderivater, fremgangsmåde til fremstilling heraf samt farmaceutiske midler indeholdende disse
DE69910068T2 (de) 17beta-acyl-17alpha-propynyl-11beta-arylsteroide und ihre derivate mit agonistischen oder antagonistischen hormonalen aktivitäten
US4416822A (en) 17β-Difluoromethyl steroids
US3200114A (en) 17-tetrahydropyranyl ethers of (3, 2-c)-pyrazole and (2, 3-d)-isoxazole derivatives o the androstane and 19-norandrostane series
EP0412907B1 (fr) Nouveaux esters d'acides organiques avec des alcools dérivés de 19-nor stéroides et leurs sels, leur procédé de préparation et les intermédiaires de ce procédé, leur application à titre de médicaments et les compositions les renfermant
US3980638A (en) Testosterone derivatives
NO168481B (no) 14,17beta-ethano-14beta-oestratrienderivater, befruktningshindrende middel, og anvendelse derav for befruktningskontroll hos kvinner.
US4567000A (en) 11-Difluoromethylene steroids
RU2091019C1 (ru) Контрацептивное средство для животных и способ его получения
US4356175A (en) 17β-Hydroxy-17α-methyl-5α-androstano-[3,2-c]pyrazole 17-methyl ether
DE2855091C3 (it)
EP0780397B1 (de) Neue 17alpha-Cyanomethylestra-4,9-dien-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
RU2099347C1 (ru) 17 α АЦЕТОКСИ-3 β БУТАНОИЛОКСИ-6-МЕТИЛПРЕГНА-4,6-ДИЕН-20-ОН, ОБЛАДАЮЩИЙ ГЕСТАГЕННОЙ АКТИВНОСТЬЮ
NZ200779A (en) 4-alpha,5-alpha-epoxy-3,20-dioxopregnane-2-alpha
US4585765A (en) 17β-hydroxy-17α-methyl-5α-androstano[3,2-c]pyrazole 17-methyl ether
EP0116329A1 (de) Neue D-Homosteroide, deren Herstellung und pharmazeutische Präparate
US3558776A (en) Pharmaceutical composition comprising 17alpha - ethynyl -17beta - hydroxy - 7alpha - methyl -5(10)-estrene-3-one
DE19961219A1 (de) 11beta-Phenylestratrien-Derivate mit Fluoralkylgruppen in der aromatischen Seitenkette, deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
CA1125278A (en) Intermediate isoxazoles
KR810001203B1 (ko) 프로스타글란딘 유도체의 제조방법
KR820000059B1 (ko) 2α-시아노-3-옥소스테로이드 유도체의 제조방법

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed